ArticleCytotechnology2022
Targeting RPL23 restores chemosensitivity of cisplatin-resistant ovarian carcinoma by inhibiting EMT.
Yujuan Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCytotechnology2022
Yujuan Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.